Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Canada/CagriSema
Purchase and availability checkCagriSema in Canada

Can you buy CagriSema in Canada?

No approved Canadian retail purchase is established by the current records. CagriSema remains an investigational fixed-dose combination, and a regulatory filing or clinical result from another market does not establish Canadian authorization, availability, or a legitimate seller.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Canada
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy CagriSema in Canada?

No approved Canadian retail purchase is established by the current records. CagriSema remains an investigational fixed-dose combination, and a regulatory filing or clinical result from another market does not establish Canadian authorization, availability, or a legitimate seller. Search Health Canada's Drug Product Database for the exact product and current market status, then verify the establishment or pharmacy and the claimed supply route separately. A local price, Canadian shipping claim, or familiar product image is not proof of approval or authentic supply.

02

Which official records should be checked for CagriSema in Canada?

Resolve the exact identity of CagriSema through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.

03

Does an online listing prove CagriSema is authorized or available in Canada?

No. A page using the name CagriSema, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

CagriSema clinical trials in Canada

13 study records currently list 156 locations in this country, including 20 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
13
Listed locations
156
Recruiting locations
20
Records with local recruiting sites
1
NCT07564414
Study-wide statusRecruiting

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Listed locations
21
Recruiting locations
20
Registry update
2026-07-08
NCT05567796
Study-wide statusActive, not recruiting

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Listed locations
7
Recruiting locations
0
Registry update
2026-07-17
NCT05669755
Study-wide statusActive, not recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Listed locations
23
Recruiting locations
0
Registry update
2026-07-17
NCT06534411
Study-wide statusCompleted

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Listed locations
13
Recruiting locations
0
Registry update
2026-07-17
NCT06065540
Study-wide statusCompleted

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Listed locations
31
Recruiting locations
0
Registry update
2026-07-08
NCT06289504
Study-wide statusCompleted

A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

Listed locations
1
Recruiting locations
0
Registry update
2026-05-19
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Canada, or keep CagriSema fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

CagriSema in North America

CagriSema across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

CagriSema is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

REDEFINE 1 Phase 3 study - NCT05567796

REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open REDEFINE 1 Phase 3 study - NCT05567796 ↗

Drug Product Database

Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug Product Database ↗

Choosing a safe online pharmacy

Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Choosing a safe online pharmacy ↗
Canada / Country guide

Canada market context.

Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.

  • Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
  • The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
  • Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the DIN

Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.

02

Verify the pharmacy

Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.

03

Separate research labels

Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05567796: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightClinicalTrials.gov
02
Drug Product DatabaseHealth Canada
03
Choosing a safe online pharmacyHealth Canada
04
Unauthorized injectable peptide warningHealth Canada
05
CagriSema study search in CanadaClinicalTrials.gov
06
NCT07564414: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightClinicalTrials.gov
07
NCT05669755: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsClinicalTrials.gov
08
NCT06534411: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothClinicalTrials.gov
09
NCT06065540: A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorClinicalTrials.gov
10
NCT06289504: A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.